A detailed history of Fayez Sarofim & CO transactions in Icon PLC stock. As of the latest transaction made, Fayez Sarofim & CO holds 403,168 shares of ICLR stock, worth $76.5 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
403,168
Previous 32,595 1136.9%
Holding current value
$76.5 Million
Previous $10.2 Million 1034.13%
% of portfolio
0.3%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$280.48 - $346.2 $104 Million - $128 Million
370,573 Added 1136.9%
403,168 $116 Million
Q2 2024

Aug 14, 2024

BUY
$288.23 - $331.73 $304,082 - $349,975
1,055 Added 3.34%
32,595 $10.2 Million
Q4 2023

Feb 14, 2024

SELL
$222.83 - $285.76 $66,849 - $85,728
-300 Reduced 0.94%
31,540 $8.93 Million
Q3 2023

Nov 14, 2023

BUY
$236.44 - $265.62 $4.37 Million - $4.91 Million
18,500 Added 138.68%
31,840 $7.84 Million
Q2 2023

Aug 14, 2023

BUY
$183.12 - $250.2 $714,168 - $975,780
3,900 Added 41.31%
13,340 $3.34 Million
Q1 2023

May 11, 2023

BUY
$193.59 - $245.33 $1.01 Million - $1.28 Million
5,200 Added 122.64%
9,440 $2.02 Million
Q3 2022

Nov 14, 2022

SELL
$183.25 - $247.5 $1,832 - $2,475
-10 Reduced 0.24%
4,240 $779,000
Q2 2022

Aug 12, 2022

BUY
$197.3 - $261.32 $5,919 - $7,839
30 Added 0.71%
4,250 $921,000
Q3 2021

Nov 15, 2021

BUY
$208.53 - $283.04 $59,431 - $80,666
285 Added 7.24%
4,220 $1.11 Million
Q2 2021

Aug 13, 2021

BUY
$194.07 - $232.2 $66,954 - $80,109
345 Added 9.61%
3,935 $813,000
Q1 2021

May 13, 2021

BUY
$171.87 - $220.96 $70,466 - $90,593
410 Added 12.89%
3,590 $705,000
Q4 2020

Feb 11, 2021

BUY
$180.3 - $214.08 $201,936 - $239,769
1,120 Added 54.37%
3,180 $620,000
Q2 2020

Aug 11, 2020

BUY
$129.79 - $170.94 $267,367 - $352,136
2,060 New
2,060 $347,000

Others Institutions Holding ICLR

About ICON PLC


  • Ticker ICLR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 81,526,600
  • Market Cap $15.5B
  • Description
  • ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development proces...
More about ICLR
Track This Portfolio

Track Fayez Sarofim & CO Portfolio

Follow Fayez Sarofim & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fayez Sarofim & CO, based on Form 13F filings with the SEC.

News

Stay updated on Fayez Sarofim & CO with notifications on news.